Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 10:3:1303723.
doi: 10.3389/fopht.2023.1303723. eCollection 2023.

Optic neuropathy in craniosynostosis

Affiliations
Review

Optic neuropathy in craniosynostosis

Tais Estrela et al. Front Ophthalmol (Lausanne). .

Abstract

Craniosynostosis (CS) or the premature fusion of one or more cranial sutures in utero, or during the first years of life, can present in isolation or as a multisystem clinical disorder with a particular impact on visual function. Among ophthalmic complications, optic neuropathy is a significant cause of irreversible vision loss in these patients. Children with CS are at higher risk of developing elevated intracranial pressure which can lead to papilledema and, ultimately, optic atrophy. In addition, sometimes associated obstructive sleep apnea, abnormalities in central nervous system venous development, and Chiari malformation may contribute to optic neuropathy. Ophthalmologists have an important role in managing a number of coexistent ophthalmologic complications such as strabismus, anisometropia, amblyopia, ptosis, and exposure keratopathy in addition to maintaining surveillance for early signs of optic neuropathy; they play a critical consultative role contributing to the decision for primary or repeat decompressive surgery. In this article, we aim to review the etiology, diagnostic approach, and management of optic neuropathies in patients with craniosynostosis.

Keywords: craniosynostosis; optic atrophy; optic neuropathy; optical coherence tomography; papilledema.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D. Genetic study of nonsyndromic coronal craniosynostosis. Am J Med Genet (1995) 55(4):500–4. doi: 10.1002/ajmg.1320550422 - DOI - PubMed
    1. Boulet SL, Rasmussen SA, Honein MA. A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 146A(8):984–91. doi: 10.1002/ajmg.a.32208 - DOI - PubMed
    1. Duan M, Skoch J, Pan BS, Shah V. Neuro-ophthalmological manifestations of craniosynostosis: current perspectives. Eye Brain (2021) 13:29–40. doi: 10.2147/EB.S234075 - DOI - PMC - PubMed
    1. Liasis A, Walters B, Thompson D, Smith K, Hayward R, Nischal KK, et al. . Visual field loss in children with craniosynostosis. Childs Nerv Syst (2011) 27(8):1289–96. doi: 10.1007/s00381-010-1378-5 - DOI - PubMed
    1. Khan SH, Nischal KK, Dean F, Hayward RD, Walker J. Visual outcomes and amblyogenic risk factors in craniosynostotic syndromes: a review of 141 cases. Br J Ophthalmol (2003) 87(8):999–1003. doi: 10.1136/bjo.87.8.999 - DOI - PMC - PubMed

LinkOut - more resources